The ATS 3f aortic bioprosthesis

James Lewis Cox*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Artificial tissue valves are less durable than artificial mechanical valves but they require less anticoagulation than mechanical valves and, thus, are associated with fewer bleeding complications. The past 40 years have witnessed persistent efforts to manufacture either a mechanical valve that does not require warfarin therapy or a tissue valve with greater long-term durability. The ATS 3f Aortic Bioprosthesis was developed specifically to address the durability problem with previously designed artificial tissue valves.

Original languageEnglish (US)
Title of host publicationAortic Root Surgery
Subtitle of host publicationThe Biological Solution
PublisherSteinkopff
Pages386-395
Number of pages10
ISBN (Print)9783798518681
DOIs
StatePublished - Dec 1 2010

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The ATS 3f aortic bioprosthesis'. Together they form a unique fingerprint.

  • Cite this

    Cox, J. L. (2010). The ATS 3f aortic bioprosthesis. In Aortic Root Surgery: The Biological Solution (pp. 386-395). Steinkopff. https://doi.org/10.1007/978-3-7985-1869-8_27